A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

Montreal Neurological Institute Clinical Research Unit, Montreal, Quebec, Canada

Brain Research Center Amsterdam, Amsterdam, North Holland, Netherlands

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Hospital Universitario Reina Sofia, Córdoba, Spain

Sahlgrenska Universitetssjukhuset, Mlndal, Sweden

Karolinska Universitetssjukhuset, Solna, Sweden

Institute of Psychiatry, Psychology and Neuroscience;Department of Old Age Psychiatry, London, Greater London, United Kingdom

Southampton General Hospital, Southampton, Hampshire, United Kingdom

Queen Elizabeth Hospital, Glasgow, Strathclyde, United Kingdom

National Hospital For Neurology and Neurosurgery, London, United Kingdom